阿迪波金是大动脉狭窄的可能风险标志物,需要手术
Nike Hansén1, Johan Ljungberg1, Ingvar A Bergdahl2
1Department of Public Health and Clinical Medicine, Medicine, Umeå University, Umeå, Sweden.
Scandinavian cardiovascular journal : SCJ
|August 18, 2023
概括
莱普可能会促进大动脉狭窄 (AS),这是一个常见的心脏膜疾病. 然而,在调整了BMI后,无论是丁还是阿迪波涅丁都没有与未来的大动脉置换 (AVR) 有显著的独立关联.
科学领域:
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
背景情况:
- 大动脉狭窄 (AS) 是成年人中最常见的膜性心脏病.
- 脂肪细胞衍生的荷尔蒙,勒和阿迪波内克丁,在新陈代谢中起着关键作用.
- 这些阿迪波金与AS进展的独立关联以及对大动脉置换 (AVR) 的需要需要进行研究.
研究的目的:
- 调查莱普和阿迪波内克丁与AS成年人未来AVR的独立关联.
- 为了确定阿迪波金水平是否预测AS患者需要手术干预.
主要方法:
- 长度病例控制研究涉及336例AVR病例和来自健康调查的匹配参考人.
- 分析了基线血清勒丁和阿迪波内克的度.
- 用于估计未来AVR风险的物流回归模型,包括验证队列.
主要成果:
- 升高的瘦素与未来的AVR没有独立关联 (OR 1.10 [0.92-1.32]),但在冠状动脉疾病 (CAD) 和>5年到AVR (1.41 [1.08-1.84]) 的患者中显示风险增加.
- 阿迪波涅丁与较高的AVR风险没有关联 (OR 0.95 [0.82-1.11]),但较高的水平与手术时≥60岁的个体的AVR风险降低相关 (0.79 [0.64-0.98]).
- 经过对体重指数 (BMI) 的调整后,关联失去了意义;验证研究显示,丁与未来的AVR相关,而阿迪波内克丁则没有.
结论:
- 阿迪波金勒普丁可能在促进大动脉狭窄症的发展方面发挥作用.
- 无论是丁还是阿迪波内克丁,在考虑BMI后,都没有显示出对未来AVR的一致,独立的预测值.
- 需要进一步的研究来阐明adipokines,肥胖和AS病变之间的复杂相互作用.
相关概念视频
Aneurysm II: Clinical Manifestations and Diagnostic Studies
10
Thoracic, aortic arch and abdominal aneurysms are significant vascular conditions that can present with various clinical manifestations and lead to serious complications. Understanding these manifestations and the appropriate diagnostic studies is essential for effective management and treatment.Thoracic Aortic AneurysmsThoracic aortic aneurysms often remain asymptomatic until they reach a size that impinges on adjacent structures. They typically cause deep, diffuse chest pain that radiates to...
10
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
119
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
119
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
13
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
13
Coronary Artery Disease I: Introduction
20
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
20
Aneurysm IV: Nursing Management
8
Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...
8
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
23
Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
23


